Insights into CYP2B6-mediated drug-drug interactions - Wikidata - wikimedia - TriplyDB

Insights into CYP2B6-mediated drug-drug interactions

Insights into CYP2B6-mediated drug-drug interactions

http://www.wikidata.org/entity/Q28078857

about

Multiple functional SNPs in differentially expressed genes modify risk and survival of non-small cell lung cancer in Chinese female non-smokers.A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects.Hepatocyte CYP2B6 Can Be Expressed in Cell Culture Systems by Exerting Physiological Levels of Shear: Implications for ADME Testing Distinctiveness of the Roma population within CYP2B6 worldwide variation.The potential of Epimedium koreanum Nakai for herb-drug interaction.Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims.Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes.Anti-retroviral drugs: current state and development in the next decade.

P2860

Q37745886-39C81CBD-839A-4B8C-B3F0-93FA0D4F1361 Q38714565-217E0A46-F136-466A-8D73-61A250939E28 Q42730547-6ECA83BB-5568-4271-8054-1FC5D3C15AC0 Q47670434-3AD1D524-273C-42CE-B23B-F1B28D8478C5 Q48218050-C1353F98-1B92-4A48-9E90-55C3EE2DBB05 Q50521741-705B4A10-7BE3-48DE-91B7-69A60489AE28 Q51365463-1AE3D9E4-0FE1-46FE-99CE-B6A65C3056AB Q54222874-5836374D-76D4-4C60-808C-06515E55BA09

P2860

Insights into CYP2B6-mediated drug-drug interactions

http://www.wikidata.org/entity/Q28078857

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Insights into CYP2B6-mediated drug-drug interactions

@ast

Insights into CYP2B6-mediated drug-drug interactions

@en

Insights into CYP2B6-mediated drug-drug interactions

@nl

type

label

Insights into CYP2B6-mediated drug-drug interactions

@ast

Insights into CYP2B6-mediated drug-drug interactions

@en

Insights into CYP2B6-mediated drug-drug interactions

@nl

prefLabel

Insights into CYP2B6-mediated drug-drug interactions

@ast

Insights into CYP2B6-mediated drug-drug interactions

@en

Insights into CYP2B6-mediated drug-drug interactions

@nl

P1433

Q28078857-C21B33B9-BDCA-408A-AC8B-E920CA3EF170

P1476

Q28078857-CD8DD76B-577A-422D-B109-DA00BDBD55DB

P2093

Q28078857-95ED7083-8E61-4479-A6FA-624092EFCC8C

Q28078857-9CB98468-473E-484B-819E-AED819A8ACDA

Q28078857-E49A4BB1-EDBD-4626-817E-C4E6F9C90747

P2860

Q28078857-0644C034-0002-4629-B138-1917D33DEED3

Q28078857-0AA2DCEA-6823-4B5B-8953-547437B5A30D

Q28078857-0B4D2BE6-D1E8-48C4-BD5D-A1A2CEDBA51B

Q28078857-0C93CA8E-F429-4D5B-A778-D5236B829AFB

Q28078857-0E46FCCB-10BD-47A1-BD42-6835CE819120

Q28078857-0E7C6C36-045A-4776-AE7E-52056BA17C11

Q28078857-1014AE8C-CAE6-4167-94F3-EC5C3022AA0C

Q28078857-12B819D3-0CC3-4A80-8DD7-AA5F0328AC3E

Q28078857-153C2E04-19D4-4ED2-8709-4620F098A775

Q28078857-17377C08-7C47-4B7A-8AA5-F1533E340C7E

P304

Q28078857-7BE072D6-569F-4898-839E-9B396AEFABED

P31

Q28078857-707D413F-CBB8-463F-B7B1-806138D480AF

P3181

Q28078857-F83A8DA9-3C80-4A53-83CE-F6E2CBC18653

P356

Q28078857-2D431D41-A9ED-4B2C-A946-04EAFEB0B415

P407

Q28078857-173FB466-DA1C-4660-8C4B-BAA986133A5B

P433

Q28078857-2B9BE6DC-1C2C-470A-BD7E-2D7038BF8874

P478

Q28078857-42238FE5-0D30-4E0D-9D2B-C890E476D846

P577

Q28078857-F5297413-A1D3-4606-A6D2-21F777079341

P698

Q28078857-890640A1-8187-4BE2-9692-AA32B138C91C

P932

Q28078857-1E695647-6152-494A-83EB-295718737475

P3181

P356

J.APSB.2016.07.016

P1433

Acta pharmaceutica Sinica B

P1476

Insights into CYP2B6-mediated drug-drug interactions

@en

P2093

Hazem E. Hassan

http://www.w3.org/2001/XMLSchema#string

Hongbing Wang

http://www.w3.org/2001/XMLSchema#string

William D. Hedrich

http://www.w3.org/2001/XMLSchema#string

P2860

The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals

Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene

Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma

The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene

Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin

Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes

Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene

P304

413-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4173520

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.APSB.2016.07.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27709010

http://www.w3.org/2001/XMLSchema#string

P932

5045548

http://www.w3.org/2001/XMLSchema#string